Welcome! The @brightmindtrial (EME 16/44/11) is funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership. The views expressed are those of the author(s) and not necessarily those of the MRC, NIHR or the Department of Health and Social Care.
Another day at the office....🎥
Great to spend the morning with @bbcemt showcasing the @brightmindtrial
If you'd like to find out more about this study into treatment-resistant depression, visit https://t.co/kSFdVn3eWI
Are you a Clinician working with individuals with treatment resistant #depression? We are assisting the
@brightmindtrial to offer non-invasive treatment using Transcranial Magnetic Stimulation. Get in contact with the R&D team for more information @BEHMHTNHS
Day 4 of #BRIGhTMIND#MeetTheTeam is Lucy Webster, Research Assistant at @NottsHealthcare. More information about the study can be found on the @ISRCTN website➡️https://t.co/5g4kBPZfUX⬅️
Well done to @NottsHealthcare for randomising 4 participants this month! Hats off to the Nottingham team for their sterling work throughout the study. Keep it up! #brightmind#welldone
Welcome to the BRIGhTMIND Twitter Page! The study is led by Chief Investigator Professor Richard Morriss, sponsored by @NottsHealthcare and funded by the NIHR EME Programme @NIHRresearch. Follow us for updates throughout the study!